Hear+Now: An AI-Powered Audio Digest – How Diagnostic Delay Changes the Way Patients Use Care

By the time many myasthenia gravis patients reach a neurology clinic, they've already spent years being misdiagnosed, dismissed, or treated for the wrong condition. That history doesn't disappear once an accurate diagnosis is made — it shapes how patients engage with care going forward. This audio digest explores how a delayed diagnostic path can affect patient trust and self-advocacy, and what that means for building a collaborative relationship from the first visit. Listen in to hear what your patients may be bringing into the room.

This audio digest was generated with the assistance of an AI tool and reviewed by a member of our Editorial Team and Health Union Medical Review Board. This information is provided for general knowledge and is not a substitute for professional medical advice.

Transcript:

Speaker 1: Today we're talking about myasthenia gravis and how diagnostic delays change the way MG patients use care. As providers treating MG, you know the clinical presentation inside and out. The goal today is examining how the specific timeline to an MG diagnosis directly alters patient behavior and the provider-patient relationship.

Speaker 2: Right. The time frame before a patient even walks into a neurology clinic, it really, you know, sets the stage for everything that follows. Understanding that timeline provides the essential context for the interactions you have in the exam room.

Speaker 1: Exactly. Looking at the 2025 Myasthenia Gravis In America survey, the data clarifies what patients may go through before reaching that exam room. It takes an average of three years to get a correct diagnosis.

Speaker 2: Yeah, and within those three years, 50% of people with MG receive at least one incorrect diagnosis first. And 47% undergo a large amount of diagnostic testing. That process involves multiple clinical evaluations, repeated imaging studies, and heavy lab work before reaching the correct answer.

Speaker 1: And 18% actually receive treatment for an incorrect diagnosis. So some patients are not simply waiting for an answer during those years; they're being actively treated for the wrong disease. Also, 32% report their symptoms were initially dismissed by providers. So, what happens to a patient's trust in the medical system with that?

Speaker 2: That history of dismissal fundamentally changes the dynamic. By the time some patients reach a neurology clinic, prior misdiagnosis or dismissal may have affected their trust in the health care system.

Speaker 1: Right.

Speaker 2: In this survey, 32% of respondents reported that their symptoms were initially dismissed by providers. For those patients, that experience may influence later interactions with specialists.

Speaker 1: The frustration is clear in the survey responses. Here is a direct quote from a patient: "I've often had my symptoms minimized and attributed to mental health issues such as depression and anxiety, when I know my body and what is my normal and my abnormal. I've been shuffled from one doctor to another."

Speaker 2: Hearing a quote like that highlights how patients enter the office already on the defensive. The provider-patient relationship starts at a deficit instead of beginning from a neutral point of trust.

Speaker 1: And that deficit connects directly to how patients subsequently manage their care. These diagnostic delays force patients to become aggressive self-advocates who heavily scrutinize their care plans.

Speaker 2: Right, they become very active in their own care.

Speaker 1: The survey data shows that 64% of MG patients actively seek out information about the latest treatments.

Speaker 2: They research mechanisms, benefits, and, you know, side effects independently. They do not just casually browse the internet. They arrive at the clinic informed, perhaps with printed clinical trial data, and prepared to question recommendations. That's because they feel their well-being depends on out-researching the system that previously failed them.

Speaker 1: Which changes how they evaluate the providers they see. Another patient quote illustrates this shift. They said, "Some of the best qualities I look for when finding a doctor are their ability to listen, their experience with myasthenia gravis specifically, and being open to working with me to find a treatment plan, not just telling me."

Speaker 2: The patient is looking for a collaborator, not just a prescriber. Because they had to fight to get an accurate diagnosis, they approach the utilization of care as an active evaluation process.

Speaker 1: Right, they require validation.

Speaker 2: Yes, they need open dialogue to counteract the years they spent being shuffled around. Providers face patients who need reassurance that their physical experiences are real and understood.

Speaker 1: So effective MG management clearly requires addressing the broken trust caused by years of misdiagnosis, rather than just prescribing treatments.

Speaker 2: Acknowledging that history shifts the focus. It moves from purely clinical management to, well, repairing the therapeutic alliance.

Speaker 1: Next time a new MG patient comes to your clinic well informed and with questions about treatment, consider what their diagnostic journey may have looked like before they reached you. Asking about prior experiences with diagnosis and care can help identify concerns, establish trust, and create a more collaborative treatment relationship from the first visit.